|
Volumn 2, Issue 1, 2005, Pages 3-10
|
Oscillating field stimulation for complete spinal cord injury in humans: a phase 1 trial.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
METHYLPREDNISOLONE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONVALESCENCE;
ELECTRODE;
ELECTROMAGNETIC FIELD;
ELECTROSTIMULATION THERAPY;
EVOKED SOMATOSENSORY RESPONSE;
FEMALE;
FOLLOW UP;
HIGH FREQUENCY VENTILATION;
HOSPITALIZATION;
HUMAN;
INSTRUMENTATION;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
NERVE REGENERATION;
PHASE 1 CLINICAL TRIAL;
PHYSIOLOGY;
SPINAL CORD INJURY;
ADOLESCENT;
ADULT;
AGED;
ANTI-INFLAMMATORY AGENTS;
COMBINED MODALITY THERAPY;
ELECTRIC STIMULATION THERAPY;
ELECTRODES, IMPLANTED;
ELECTROMAGNETIC FIELDS;
EVOKED POTENTIALS, SOMATOSENSORY;
FEMALE;
FOLLOW-UP STUDIES;
HIGH-FREQUENCY VENTILATION;
HUMANS;
MALE;
METHYLPREDNISOLONE;
MIDDLE AGED;
NERVE REGENERATION;
RECOVERY OF FUNCTION;
SEVERITY OF ILLNESS INDEX;
SPINAL CORD INJURIES;
|
EID: 13844280465
PISSN: 15475654
EISSN: None
Source Type: Journal
DOI: 10.3171/spi.2005.2.1.0003 Document Type: Article |
Times cited : (167)
|
References (0)
|